PROFESSIONAL EDITION

The largest community of pharma leaders

PharmaCyte Biotech Begins Physical Testing of CypCaps in Response to FDA Recommendations for its Clinical Trial Product

LAGUNA HILLS, Calif.–(BUSINESS WIRE)– #INDstatus–PharmaCyte Biotech begins testing of its clinical trial product in response to the FDA’s recommendations to lift the clinical hold.

Source Business Wire Health: Pharmaceutical NewsRead More

Recent Articles